8
Oct
2024

Damaira Pharmaceuticals pvt Ltd

Exhibitor at CPHI Milan 2024 stand 16G70, Finished Dosage Formulations
About Us

Damaira Pharmaceuticals runs a well-established manufacturing facility which is solely dedicated to the production of FinshedCarbapenem Dry Powder Injections, a class of strong antibiotics used for treating severe bacterial infections.

The facility is based on norms laid out by strict regulatory authorities and all measures taken are at par with international standards to assure high quality of medicines.

Damaira Pharmaceuticals specialises in producing life-saving drugs that are used as last-resort treatment for severe bacterial infections. We recognise the...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IN
  • 2023
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
Hospital / Health Centre
Pharmaceutical company
Primary activities
Finished Formulation products Distributor/Buyer
Pharmaceutical Company (innovator finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 16G70, Finished Dosage Formulations

Products Featured at CPHI Milan 2024

  • Imipenem Cilastatin

    Product Imipenem Cilastatin

    Imipenem Cilastatin is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below

     

    Lower respiratory tract infectionsUrinary tract infections (complicated and uncomplicated)Intra-abdominal infec...
  • Meropenem

    Product Meropenem

    Meropenem is indicated for all age group including infants above 3 months of age as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms:

    Pneumonias and Nosocomial PneumoniasUrinary Tract InfectionsIntra-abdominal...